| | | | | | | | | | |
|
|
| Dockets Entered
On November 5, 2003
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1978N-0036L
|
| OTC Laxative
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
| 2003D-0380
|
| Draft Guidance for Industry: PAT - A Framework for Innovative Pharmaceutical Manufacturing and Quality Assurance; Availability
|
|
|
| 2003D-0382
|
| Draft Guidance: Sterile Drug Products Produced by Aseptic Processing
|
|
|
| 2003D-0383
|
| Draft Guidance for Industry and FDA Staff; Use of Symbols on Labels and in Labeling of In Vitro Diagnostic Devices Intended for Professional Use; Availability
|
|
|
| 2003D-0478
|
| Guidance on Marketed Unapproved Drugs Compliance Policy Guide
|
|
|
| 2003M-0487
|
| P020007 - Medtronic AVE Bridge Extra Support Over-the-Wire (OTW) Renal Stent System
|
|
|
| 2003M-0488
|
| P020041- FemCap Barrier Contraceptive
|
|
|
| 2003M-0490
|
| P030009 - Medtronic Vascular Driver Over-the-Wire, Rapid Exchange, and Multi-Exchange Coronary Stent Systems
|
|
|
| 2003M-0491
|
| P020050 - WaveLight ALLEGRETTO WAVE Excimer Laser System
|
|
|
| 2003M-0492
|
| P030008 - WaveLight ALLEGRETTO WAVE Excimer Laser System
|
|
|
| 2003M-0499
|
| P020047 - MULTI-LINK RX and OTW VISION Coronary Stent Systems
|
|
|
| 2003N-0361
|
| Anti-Counterfeit Drug Initiative
|
|
|
| 2003N-0400
|
| Control of Communicable Diseases; Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals
|
|
|
| 2003P-0517
|
| Determine that Pennifield is not now, and never has been eligible for interim marketing for bacitracin MD
|
|
|
| 2003P-0518
|
| Refrain from approving any Abbreviated New Drug Application for sirolimus with Rapamune (sirolimus)
|
|
|
| 2003V-0510
|
| Laser Light Show
|
|
|
| 2003V-0514
|
| Laser Light Show
|
|
|
| 2003V-0515
|
| Laser Display Device
|
|
|
| 2003V-0516
|
| Laser Light Show
|
|
|
| 1978N-0036L
|
| OTC Laxative
|
|
|
| C
206
Tab
1, 2,
3, 4, 5
|
| Madaus AG (Madaus)
|
| Vol #:
|
| 121
|
|
|
| LET
202
|
| The Purdue Frederick Company (Purdue)
|
| Vol #:
|
| 121
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
| LET
11465
|
| Evolution-X
|
| Vol #:
|
| 89
|
|
|
| LET
11466
|
| Herbo, Inc.
|
| Vol #:
|
| 89
|
|
|
| LET
11467
|
| Herbo, Inc.
|
| Vol #:
|
| 89
|
|
|
| LET
11468
|
| Herbo, Inc.
|
| Vol #:
|
| 89
|
|
|
| LET
11469
|
| Herbo, Inc.
|
| Vol #:
|
| 89
|
|
|
| LET
11470
|
| Herbo, Inc.
|
| Vol #:
|
| 89
|
|
|
| LET
11471
|
| Herbo, Inc.
|
| Vol #:
|
| 89
|
|
|
| LET
11472
|
| Herbo, Inc.
|
| Vol #:
|
| 89
|
|
|
| LET
11473
|
| Herbo, Inc.
|
| Vol #:
|
| 89
|
|
|
| LET
11474
|
| Herbo, Inc.
|
| Vol #:
|
| 89
|
|
|
| LET
11475
|
| Herbo, Inc.
|
| Vol #:
|
| 89
|
|
| | | | | | | | |
|
|
| LET
11476
|
| Herbo, Inc.
|
| Vol #:
|
| 89
|
|
|
| LET
11477
|
| Herbo, Inc.
|
| Vol #:
|
| 89
|
|
|
| LET
11478
|
| Herbo, Inc.
|
| Vol #:
|
| 89
|
|
|
| LET
11479
|
| Herbo, Inc.
|
| Vol #:
|
| 89
|
|
|
| LET
11480
|
| Herbo, Inc.
|
| Vol #:
|
| 89
|
|
|
| LET
11481
|
| Herbo, Inc.
|
| Vol #:
|
| 89
|
|
|
| LET
11482
|
| Solgar Vitamin & Herbs
|
| Vol #:
|
| 89
|
|
|
| LET
11483
|
| Recovery Pharmaceuticals, Inc.
|
| Vol #:
|
| 89
|
|
|
| LET
11484
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 89
|
|
|
| LET
11485
|
| Natrol, Inc.
|
| Vol #:
|
| 89
|
|
|
| LET
11486
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 89
|
|
|
| 2003D-0380
|
| Draft Guidance for Industry: PAT - A Framework for Innovative Pharmaceutical Manufacturing and Quality Assurance; Availability
|
|
|
| EMC
2
|
| Facility Automation Management
Engineering Systems
|
| Vol #:
|
| 1
|
|
|
| EMC
3
Attachment
|
| H. Lundbeck A/S
|
| Vol #:
|
| 1
|
|
|
| EMC
4
|
| Eli Lilly and Company
|
| Vol #:
|
| 1
|
|
|
| EMC
5
|
| Pfizer, Inc.
|
| Vol #:
|
| 1
|
|
|
| EMC
6
|
| GlaxoSmithKline
|
| Vol #:
|
| 1
|
|
|
| 2003D-0382
|
| Draft Guidance: Sterile Drug Products Produced by Aseptic Processing
|
|
|
| EMC
9
Enclosure
|
| European Federation of Pharmaceutical Industries and Associations (EFPIA)
|
| Vol #:
|
| 2
|
|
|
| EMC
10
Enclosure
|
| European Federation of Pharmaceutical Industries and Associations (EFPIA)
|
| Vol #:
|
| 2
|
|
|
| EMC
11
|
| Pfizer, Inc.
|
| Vol #:
|
| 2
|
|
|
| EMC
12
|
| Skan AG
|
| Vol #:
|
| 2
|
|
|
| EMC
13
|
| Robert BOSCH GmbH
|
| Vol #:
|
| 2
|
|
|
| EMC
14
Attachment
|
| Aventis Behring
|
| Vol #:
|
| 2
|
|
|
| EMC
15
|
| GlaxoSmithKline
|
| Vol #:
|
| 2
|
|
|
| EMC
16
|
| B. Braun Medical, Inc.
|
| Vol #:
|
| 2
|
|
|
| EMC
17
Attachment
|
| International Assn for Pharmaceutical Science and Technology (PDA)
|
| Vol #:
|
| 2
|
|
|
| EMC
18
|
| Parenteral Society
|
| Vol #:
|
| 2
|
|
|
| EMC
19
|
| Parenteral Society
|
| Vol #:
|
| 2
|
|
|
| 2003D-0383
|
| Draft Guidance for Industry and FDA Staff; Use of Symbols on Labels and in Labeling of In Vitro Diagnostic Devices Intended for Professional Use; Availability
|
|
|
| EMC
1
|
| Future Diagnostics B.V.
|
| Vol #:
|
| 1
|
|
|
| 2003D-0478
|
| Guidance on Marketed Unapproved Drugs Compliance Policy Guide
|
|
|
| EMC 9
|
| Winston Wiley
|
| Vol #:
|
| 1
|
|
|
| EMC 10
|
| Sunil Shah
|
| Vol #:
|
| 1
|
|
| | | | | | | | |
|
|
| 2003M-0487
|
| P020007 - Medtronic AVE Bridge Extra Support Over-the-Wire (OTW) Renal Stent System
|
|
|
| AAV
1
Approval
order, SSED, Labelling
|
| Medtronic AVE, Inc.
|
| Vol #:
|
| 1
|
|
|
| 2003M-0488
|
| P020041- FemCap Barrier Contraceptive
|
|
|
| AAV
1
Approval
order, SSED, Labelling
|
| FemCap, Inc.
|
| Vol #:
|
| 1
|
|
|
| 2003M-0490
|
| P030009 - Medtronic Vascular Driver Over-the-Wire, Rapid Exchange, and Multi-Exchange Coronary Stent Systems
|
|
|
| AAV
1
Approval
order, SSED, Labelling
|
| Medtornic Vascular
|
| Vol #:
|
| 1
|
|
|
| 2003M-0491
|
| P020050 - WaveLight ALLEGRETTO WAVE Excimer Laser System
|
|
|
| AAV
1
Approval
order, SSED, Labelling
|
| Surgi-Vision Refractive Consultants, LLC
|
| Vol #:
|
| 1
|
|
|
| 2003M-0492
|
| P030008 - WaveLight ALLEGRETTO WAVE Excimer Laser System
|
|
|
| AAV
1
Approval
order, SSED, Labelling
|
| Surgi-Vision Refractive Consultants, LLC
|
| Vol #:
|
| 1
|
|
|
| 2003M-0499
|
| P020047 - MULTI-LINK RX and OTW VISION Coronary Stent Systems
|
|
|
| AAV
1
Approval
order, SSED, Labelling
|
| Guidant Corporation
|
| Vol #:
|
| 1
|
|
|
| 2003N-0361
|
| Anti-Counterfeit Drug Initiative
|
|
|
| EMC 8
|
| M Cappuccio
|
| Vol #:
|
| 4
|
|
|
| EMC
9
|
| Academy of Managed Care Pharmacy (AMCP)
|
| Vol #:
|
| 4
|
|
|
| EMC
10
Attachment 1,
2, 3,
4
|
| Kezzler AS
|
| Vol #:
|
| 4
|
|
|
| EMC
11
|
| TSSI
|
| Vol #:
|
| 4
|
|
|
| EMC
12
Attachment 1,
2
|
| Uniform Code Council, Inc. (UCC)
|
| Vol #:
|
| 4
|
|
|
| EMC
13
Attachment 1,
2
|
| Uniform Code Council, Inc. (UCC)
|
| Vol #:
|
| 4
|
|
|
| EMC
14
|
| Tracer Detection Technology Corp.
|
| Vol #:
|
| 4
|
|
|
| EMC 15
|
| Number not Used
|
| Vol #:
|
| 4
|
|
|
| EMC
16
|
| West Pharmaceutical Services, Inc.
|
| Vol #:
|
| 4
|
|
|
| EMC
17
|
| American Medical Assn (AMA)
|
| Vol #:
|
| 4
|
|
|
| EMC
18
|
| GlaxoSmithKline
|
| Vol #:
|
| 4
|
|
|
| EMC
19
|
| Biotechnology Industry Organization (BIO)
|
| Vol #:
|
| 4
|
|
|
| EMC
20
|
| National Assn of Chain Drug Stores (NACDS)
|
| Vol #:
|
| 4
|
|
|
| EMC
21
|
| Amgen Inc. (Amgen)
|
| Vol #:
|
| 4
|
|
|
| EMC
22
|
| Merck & Co., Inc.
|
| Vol #:
|
| 4
|
|
|
| EMC
23
|
| Anda, Inc.
|
| Vol #:
|
| 4
|
|
|
| EMC
24
|
| NNC Group, LLC
|
| Vol #:
|
| 4
|
|
|
| EMC
25
Attachment 1,
2
|
| Sun Microsystems, Inc. (Sun)
|
| Vol #:
|
| 4
|
|
|
| EMC 26
|
| Number Not Used
|
| Vol #:
|
| 4
|
|
|
| EMC
27
|
| American Pharmacists Assn (APhA)
|
| Vol #:
|
| 4
|
|
| | | | | | | | |
|
|
| EMC
28
|
| McKesson Corporation (McKesson)
|
| Vol #:
|
| 4
|
|
|
| EMC
29
Attachment 1,
2, 3
|
| Zebra Technologies Corporation
|
| Vol #:
|
| 4
|
|
|
| EMC
30
|
| FFF Enterprises (FFF)
|
| Vol #:
|
| 4
|
|
|
| 2003N-0400
|
| Control of Communicable Diseases; Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals
|
|
|
| EMC 1
|
| Thomas G. Crouthamel, Sr.
|
| Vol #:
|
| 1
|
|
|
| 2003P-0517
|
| Determine that Pennifield is not now, and never has been eligible for interim marketing for bacitracin MD
|
|
|
| ACK 1
|
| HFA-305 to Alpharma Inc.
|
| Vol #:
|
| 1
|
|
|
| CP
1
Tab 1,
2, 3,
4, 5,
6, 7,
8, 9,
10
|
| Alpharma Inc.
|
| Vol #:
|
| 1
|
|
|
| 2003P-0518
|
| Refrain from approving any Abbreviated New Drug Application for sirolimus with Rapamune (sirolimus)
|
|
|
| ACK 1
|
| HFA-305 to Wyeth Pharmaceuticals
|
| Vol #:
|
| 1
|
|
|
| CP
1
|
| Wyeth Pharmaceuticals
|
| Vol #:
|
| 1
|
|
|
| 2003V-0510
|
| Laser Light Show
|
|
|
| ACK 1
|
| HFA-305 to InterVision
|
| Vol #:
|
| 1
|
|
|
| 2003V-0514
|
| Laser Light Show
|
|
| ACK 1
|
| HFA-305 to Heritage Planetarium
|
| Vol #:
|
| 1
|
|
|
| VAR
1
|
| Heritage Planetarium
|
| Vol #:
|
| 1
|
|
|
| 2003V-0515
|
| Laser Display Device
|
|
|
| ACK 1
|
| HFA-305 to Full House Productions L. L. C.
|
| Vol #:
|
| 1
|
|
|
| VAR
1
|
| Full House Productions L. L. C.
|
| Vol #:
|
| 1
|
|
|
| 2003V-0516
|
| Laser Light Show
|
|
|
| VAR
1
|
| Vanderbilt Museum Planetarium
|
| Vol #:
|
| 1
|
|
|